Pharmacists in Wenatchee, Washington


125 Pharmacists found in Wenatchee
male pharmacist

Timothy Diggs, PHARMD, RPH


Pharmacist
1201 S Miller St, Wenatchee, WA 98801
509-662-1511    

male pharmacist

Tony Tran



820 N Chelan Ave, Wenatchee, WA 98801
509-663-8711    

female pharmacist

Tracy Morton, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
820 N Chelan Ave, Wenatchee, WA 98801
509-663-8711     509-665-5870



male pharmacist

Dr. Travis Iksic, PHARMD


Pharmacist
1340 N Wenatchee Ave, Wenatchee, WA 98801
509-664-5111     509-663-9006

male pharmacist

Troy Toftness


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1683 Pitcher Canyon Rd, Wenatchee, WA 98801
509-662-7906    

female pharmacist

Tulip Younes, PHARMD


Pharmacist
1201 S Miller St, Wenatchee, WA 98801
506-662-1511    

male pharmacist

Tyler John Andrysczyk, PHARM D.


Pharmacist
501 N Miller St, Wenatchee, WA 98801
509-663-5336    

female pharmacist

Valerie Barnett, PHARMD


Pharmacist
820 N Chelan Ave, Wenatchee, WA 98801
509-665-5888    

female pharmacist

Victoria B Chong


Pharmacist
820 N Chelan Ave, Wenatchee, WA 98801
509-663-8711    

male pharmacist

Vijay Atwal


Pharmacist
501 N Miller St, Wenatchee, WA 98801
509-663-5336    

male pharmacist

William Gibson


Pharmacist - Pharmacotherapy
1201 S Miller St, Wenatchee, WA 98801
509-662-1511    

female pharmacist

Yetunde Odutayo


Pharmacist
1128 N Miller St, Wenatchee, WA 98801
509-663-8547    

male pharmacist

Dr. Zachary Miller, PHARMD


Pharmacist
820 N Chelan Ave, Wenatchee, WA 98801
509-663-8711    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.